• Publications
  • Influence
[Angiotensin-II receptor blockers].
Adults Angiotensin II receptor blockers (ARBs) as monotherapy are FDA-approved for use in hypertension (all available ARBs), diabetic nephropathy (irbesartan, losartan), heart failure (candesartan,Expand
  • 66
  • 4
Prevalence of ischaemic heart disease, arterial hypertension and intermittent claudication, and distribution of risk factors among middle-aged men in Moscow and Berlin.
The initial examinations of prospective epidemiological studies of the same kind performed in random samples of 50-54 years old men from Moscow and Berlin showed the following prevalence rates (eachExpand
  • 27
  • 2
Identification of a prazosin metabolite and some preliminary data on its kinetics in hypertensive patients
SummaryA metabolite of prazosin was detected in serum from hypertensive patients treated with prazosin. Its structure as 2-(1-piperazinyl)-4-amino-6,7-dimethoxyquinazoline was established by UV, IR,Expand
  • 7
  • 1
[Pharmacological agents in controlling smoking].
  • 1
  • 1
[The epidemiology of ischemic heart disease].
  • 10
The effect of oral verapamil therapy on antipyrine clearance.
The influence of chronic verapamil treatment on antipyrine elimination was studied in eight angina patients. Antipyrine half-life (mean +/- s.d.) was 13.1 +/- 1.15 h at the start of therapy and 16.6Expand
  • 22
Enhancement of the efficacy of isosorbide dinitrate by captopril in stable angina pectoris.
This study was designed to assess whether the angiotensin-converting enzyme inhibitor captopril could potentiate the efficacy of a single dose of oral isosorbide dinitrate (ISDN) in patients withExpand
  • 15
Development of tolerance to nifedipine in patients with stable angina pectoris.
1. The possibility of development of tolerance to the anti-ischaemic and anti-anginal effects of nifedipine during sustained administration for 2 months was studied in 15 patients with stable anginaExpand
  • 7